BOLD Capital Partners
BOLD Capital Partners — Santa Monica (CA, USA) venture capital firm founded 2015 by Peter Diamandis. Early-stage VC in deep technology, life sciences, healthcare, longevity, and frontier tech. Two vehicles confirmed: BOLD Capital Partners Fund I (2015, USD 300M defensive) for early stage + BOLD Longevity Growth (2023, Boston-based, USD 400M defensive) for late-stage longevity biotech and AI. Per Tracxn / WebSearch, ~60+ portfolio companies (Akitra, AliveCor, Aqtual, Atomiton, CareSignal etc.). Site boldcapitalpartners.com is JS-rendered — full per-co entry-year extraction deferred. NOTE: this GP is a US firm and is OUT OF PRIMARY SCOPE for gp-intel.com (FR-focused). Kept for cross-pollination value (overlapping deep-tech / longevity portfolio with EU GPs) but not actively maintained.
Key facts
Recent exits
No exits recorded yet.
Coverage notes
2 funds tracked, 63 portfolio companies (63 active · 0 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund BOLD Capital Partners has raised, with its portfolio companies. Hand-checked from public filings.
BOLD Longevity GrowthGrowth2023 · 3yr€400M3 active
Unrealized
3 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Aqtual | Software | France | – |
| Deep Longevity | Healthcare | France | – |
| Stealth Longevity Company | Healthcare | France | – |
BOLD Capital Partners Fund IVC2015 · 11yr€300M60 active
Unrealized
60 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Akitra | Software | France | – |
| AliveCor | Healthcare | US | – |
| Atomiton | TMT | France | – |
| Bionaut Labs | Healthcare | France | 2023 |
| CareSignal | Healthcare | France | – |
| Chef Robotics | TMT | France | – |
| Colossal | Healthcare | France | – |
| Crowdz | TMT | US | – |
| Curebase | Healthcare | France | – |
| Deciduous Therapeutics | Healthcare | France | – |
| DigiLens | TMT | France | – |
| Discure | Healthcare | France | – |
| Docbot | Software | France | – |
| Dreamscape Immersive | TMT | France | – |
| Dreamscape Learn | TMT | France | – |
| Earth Force | Industrials | US | – |
| Elevian | Healthcare | France | – |
| eXo | Software | France | – |
| Feno Labs | Software | France | – |
| Figure AI | Software | US | – |
| Form Bio | Healthcare | France | – |
| Fountain Therapeutic Services | Healthcare | France | – |
| Gallant Pet | Consumer | US | – |
| Gameto | Healthcare | US | – |
| GuRu | TMT | France | – |
| Holoclara | TMT | France | – |
| Human in Motion Robotics | Software | US | – |
| Hyperloop One | TMT | US | – |
| Immunis Biomedical | Healthcare | France | – |
| Insilico Medicine | Healthcare | France | – |
| iota Biosciences | Healthcare | France | 2023 |
| Iviva Medical | Healthcare | France | – |
| KeyCare | Healthcare | US | – |
| Kindred | TMT | France | – |
| Liquid AI | Software | US | – |
| MagicCube | TMT | France | – |
| Matrisome Bio | Healthcare | France | 2023 |
| Meru Health | Healthcare | France | – |
| Metawave | TMT | France | – |
| Mighty Buildings | Industrials | US | – |
| Mojo Vision | TMT | France | – |
| Neutrino8 | TMT | France | – |
| Omeat | Consumer | France | – |
| Openwater | Healthcare | US | – |
| OURA Health | Healthcare | France | – |
| ParkourSC | TMT | France | – |
| Proprio | Healthcare | France | – |
| ProRata.ai | Software | France | – |
| Relativity Space | TMT | US | – |
| Rugged Robotics | TMT | US | – |
| SeQureDX | Healthcare | France | – |
| Singularity | Software | US | – |
| Solarea Bio | Healthcare | France | 2023 |
| Stuff That Works | Software | France | – |
| Switch Therapeutics | Healthcare | France | – |
| Symbiome | Healthcare | France | 2023 |
| Synadia | Software | US | – |
| Syntis Bio | Healthcare | France | – |
| Terramera | Industrials | Canada | – |
| Viome | Healthcare | France | – |
Saved GPs appear in your watchlist, one click from your workspace.
About BOLD Capital Partners
BOLD Capital Partners is a American venture capital firm headquartered in New York with €700 million of assets under management as of December 2024. Founded in 2015, the firm deploys institutional capital across early-stage and selective growth-stage equity rounds in European technology companies, with sector focus spanning consumer, software, healthcare and business services.
Investment thesis
BOLD Capital Partners targets European and selectively global early-stage and growth-stage technology companies across consumer, software, healthcare and business services, deploying institutional venture capital across seed, Series A and Series B rounds. The firm emphasises hands-on operational support during the post-investment value-creation phase, leveraging founder and operator partners alongside institutional capital to support international expansion and category leadership across North America with selective European deployment. Average equity tickets vary by stage with reserve capital preserved for follow-on rounds across the platform.
Recent activity
Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 2 fund vehicles, 63 active portfolio companies and 0 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
United StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited States